Bausch + Lomb (NYSE: BLCO) — Company Overview, News & Financial Data
Bausch + Lomb focuses on eye health, manufacturing contact lenses and surgical instruments for diverse vision care needs.
Bausch + Lomb
Bausch + Lomb (NYSE:BLCO) is a well-known company focused on eye health, engaging in a broad range of activities aimed at improving the sight and lives of people worldwide. Its operations span across the manufacture and sale of contact lenses, surgical instruments, eye care products, and pharmaceuticals dedicated to treating a variety of eye conditions. With a rich history of innovation, Bausch + Lomb is committed to advancing the field of vision care through the development of new technologies and treatments. The company's objectives are centered on enhancing patient care and leading the industry in sustainable practices. Through ongoing research and development projects, Bausch + Lomb strives to meet the evolving needs of both eye care professionals and patients, ensuring everyone has access to the best possible eye health solutions.
Snapshot
Operations
Products and/or services of Bausch + Lomb
- Contact lenses including soft, daily disposables, and extended wear options, providing vision correction and comfort.
- Pharmaceuticals for eye conditions such as glaucoma, eye infections, and dry eye syndrome.
- Surgical products including intraocular lenses and devices for cataract and retinal surgery.
- Over-the-counter products like eye vitamins, drops for dry eyes, and lens care solutions.
- Vision care products including contact lens care solutions, eye washes, and ocular vitamins for eye health maintenance.
- Aesthetic devices for treatments like laser skin rejuvenation and hair removal.
Bausch + Lomb executive team
- Alan WaterhouseExecutive VP and Chief Supply Chain & Operations Officer
- Frederick J. MunschSenior VP, Controller & Chief Accounting Officer
- George GadkowskiVP & Head of Investor Relations & Business Insights
- Jonathon L. KellermanChief Compliance Officer
- T.J. CrawfordChief Communications Officer
- Manisha A. NarasimhanChief Corporate Development & Digital Officer
- Asli GevgililiExecutive VP & Chief Human Resources Officer
- Luc BonnefoyPresident of Surgical
- John FerrisPresident of Consumer
- Yang YangPresident of Vision Care
Latest news about Bausch + Lomb
Bausch + Lomb wins CE Mark for SeeLyra laser
United StatesBausch + Lomb launches advanced Eye vitamin, target market expands to early-stage AMD
United StatesBausch + Lomb secures FDA clearance for advanced vitrectomy technology
United StatesBausch + Lomb hits pivotal milestones for ELIOS glaucoma laser system
United StatesBausch + Lomb Q4 revenue climbs 10% to $1.4 billion
United States
Key financials
Reported results for Bausch + Lomb , in USD.
- Market cap
- 7.3B
- Revenue (TTM)
- 5.3B
- P/E ratio
- —
- EPS (diluted, TTM)
- -0.3
- Dividend yield
- —
- Profit margin
- -3.2%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 5.1B | 188M | -360M | |
| 4.8B | 162M | -317M | |
| 4.1B | 130M | -260M | |
| 3.8B | 207M | 6M |